Replies to post #15323 on The Rising Influence of Rising Affluence

[DewDiligence]

Barron’s still likes MDT—even at its much higher valuation:

https://www.barrons.com/articles/another-reason-to-like-medtronic-shares-51573870541

This write-up features the Micra pacemaker.

The previous Barron’s write-up on MDT was in Aug 2017 (#msg-134152817). The stock is up 48% since then.